A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. (2023)

First Author: Halford S
Attributed to:  MICA: The Newcastle Proximity Laboratory funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-22-2263

PubMed Identifier: 36652553

Publication URI: http://europepmc.org/abstract/MED/36652553

Type: Journal Article/Review

Volume: 29

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 8

ISSN: 1078-0432